UB Paderborn / Katalog / Suche / in CDI

Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer

Cancer cell, 2005-09, Vol.8 (3), p.227-239

2005

Volltextzugriff (PDF)

Complexity of miR-223 regulation by CEBPA in human AML

Leukemia research, 2010-05, Vol.34 (5), p.672-676

2010

Volltextzugriff (PDF)

Functional interplay of SP family members and nuclear factor Y is essential for transcriptional activation of the human Calreticulin gene

Biochimica et biophysica acta, 2015-09, Vol.1849 (9), p.1188-1197

2015

Volltextzugriff (PDF)

Activation of the Unfolded Protein Response in Human Acute Myeloid Leukemia

Methods in Enzymology, 2011, Vol.489, p.227-243

2011

Volltextzugriff (PDF)

Inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5

FEBS letters, 2010-07, Vol.584 (13), p.2867-2871

2010

Volltextzugriff (PDF)

Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia

Journal of cellular and molecular medicine, 2010-06, Vol.14 (6b), p.1509-1519

2010

Volltextzugriff (PDF)

SCOMP Is Superior to Degenerated Oligonucleotide Primed-Polymerase Chain Reaction for Global Amplification of Minute Amounts of DNA from Microdissected Archival Tissue Samples

The American journal of pathology, 2002-07, Vol.161 (1), p.43-51

2002

Volltextzugriff (PDF)

The use of immune checkpoint inhibitors in routine oncology

Zeitschrift für Rheumatologie, 2020-10, Vol.79 (8), p.809-817

Schardt, Julian

2020

Volltextzugriff (PDF)

Der Einsatz von Immuncheckpoint-Inhibitoren im onkologischen Alltag

Zeitschrift für Rheumatologie, 2020-01, Vol.79 (8), p.809-817

Schardt, Julian

2020

Volltextzugriff (PDF)

Forty years of cisplatin-based chemotherapy in muscle-invasive bladder cancer: are we understanding how, who and when?

World journal of urology, 2019-09, Vol.37 (9), p.1759-1765

2019

Volltextzugriff (PDF)

Somatic CEBPA Mutations Are a Frequent Second Event in Families With Germline CEBPA Mutations and Familial Acute Myeloid Leukemia

Journal of clinical oncology, 2008-11, Vol.26 (31), p.5088-5093

2008

Volltextzugriff (PDF)

Sulfobetaine Methacrylate Polymers of Unconventional Polyzwitterion Architecture and Their Antifouling Properties

Biomacromolecules, 2021-04, Vol.22 (4), p.1494-1508

2021

Volltextzugriff (PDF)

Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial

Bone marrow transplantation (Basingstoke), 2022-06, Vol.57 (6), p.990-997

2022

Volltextzugriff (PDF)

Low Fouling Polysulfobetaines with Variable Hydrophobic Content

Macromolecular rapid communications., 2022-06, Vol.43 (12), p.e2100589-n/a

2022

Volltextzugriff (PDF)

Effect of Dipole Orientation in Mixed, Charge-Equilibrated Self-assembled Monolayers on Protein Adsorption and Marine Biofouling

ACS applied materials & interfaces, 2020-11, Vol.12 (45), p.50953-50961

2020

Volltextzugriff (PDF)

Safety and efficacy of perioperative cisplatin/gemcitabine (cis/gem) and durvalumab (durva) for operable muscle-invasive urothelial carcinoma (MIUC): SAKK 06/17

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.430-430

2021

Volltextzugriff (PDF)

Long lasting response to anti-PD-1 therapy of recurrent conjunctival squamous cell carcinoma - A case report and systematic review of the literature

Current problems in cancer. Case reports, 2021-12, Vol.4, p.100088, Article 100088

2021

Volltextzugriff (PDF)

Response to first-line treatment and histology are associated with achieving complete remission after the first salvage high-dose chemotherapy in relapsing germ cell tumor patients

Bone marrow transplantation (Basingstoke), 2018-07, Vol.53 (7), p.820-825

2018

Volltextzugriff (PDF)

Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML

Blood, 2011-06, Vol.117 (22), p.5931-5940

2011

Volltextzugriff (PDF)

Perioperative chemoimmunotherapy with durvalumab (Durva) in combination with cisplatin/gemcitabine (Cis/Gem) for operable muscle-invasive urothelial carcinoma (MIUC): Preplanned interim analysis of a single-arm phase II trial (SAKK 06/17)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.499-499

2020

Volltextzugriff (PDF)

The Unfolded Protein Response (UPR) Is Activated in Human Acute Myeloid Leukemia (AML) and Suppresses Translation of the CCAAT/Enhancer Binding Protein-Alpha (CEBPA) by Induction of the RNA-Binding Protein Calreticulin

Blood, 2008-11, Vol.112 (11), p.2934-2934

2008

Volltextzugriff (PDF)

Activation of the Unfolded Protein Response (UPR) Induces CEBPA mRNA Decay in AML Cells

Blood, 2008-11, Vol.112 (11), p.2258-2258

2008

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer

Complexity of miR-223 regulation by CEBPA in human AML

Functional interplay of SP family members and nuclear factor Y is essential for transcriptional activation of the human Calreticulin gene

Activation of the Unfolded Protein Response in Human Acute Myeloid Leukemia

Inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5

Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia

SCOMP Is Superior to Degenerated Oligonucleotide Primed-Polymerase Chain Reaction for Global Amplification of Minute Amounts of DNA from Microdissected Archival Tissue Samples

The use of immune checkpoint inhibitors in routine oncology

Der Einsatz von Immuncheckpoint-Inhibitoren im onkologischen Alltag

Forty years of cisplatin-based chemotherapy in muscle-invasive bladder cancer: are we understanding how, who and when?

Somatic CEBPA Mutations Are a Frequent Second Event in Families With Germline CEBPA Mutations and Familial Acute Myeloid Leukemia

Sulfobetaine Methacrylate Polymers of Unconventional Polyzwitterion Architecture and Their Antifouling Properties

Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial

Low Fouling Polysulfobetaines with Variable Hydrophobic Content

Effect of Dipole Orientation in Mixed, Charge-Equilibrated Self-assembled Monolayers on Protein Adsorption and Marine Biofouling

Safety and efficacy of perioperative cisplatin/gemcitabine (cis/gem) and durvalumab (durva) for operable muscle-invasive urothelial carcinoma (MIUC): SAKK 06/17

Long lasting response to anti-PD-1 therapy of recurrent conjunctival squamous cell carcinoma - A case report and systematic review of the literature

Response to first-line treatment and histology are associated with achieving complete remission after the first salvage high-dose chemotherapy in relapsing germ cell tumor patients

Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML

Perioperative chemoimmunotherapy with durvalumab (Durva) in combination with cisplatin/gemcitabine (Cis/Gem) for operable muscle-invasive urothelial carcinoma (MIUC): Preplanned interim analysis of a single-arm phase II trial (SAKK 06/17)

The Unfolded Protein Response (UPR) Is Activated in Human Acute Myeloid Leukemia (AML) and Suppresses Translation of the CCAAT/Enhancer Binding Protein-Alpha (CEBPA) by Induction of the RNA-Binding Protein Calreticulin

Activation of the Unfolded Protein Response (UPR) Induces CEBPA mRNA Decay in AML Cells

Aktive Filter

Suchergebnisse filtern